0001104659-07-046544 Sample Contracts
Amylin Pharmaceuticals, Inc. Registration Rights AgreementRegistration Rights Agreement • June 8th, 2007 • Amylin Pharmaceuticals Inc • Pharmaceutical preparations • New York
Amylin Pharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the Purchasers (as defined herein) upon the terms set forth in the Purchase Agreement (as defined herein) its 3.00% Convertible Senior Notes due 2014 (the “Securities”). As an inducement to the Purchasers to enter into the Purchase Agreement and in satisfaction of a condition to the obligations of the Purchasers thereunder, the Company agrees with the Purchasers for the benefit of Holders (as defined herein) from time to time of the Registrable Securities (as defined herein) as follows:
Purchase AgreementPurchase Agreement • June 8th, 2007 • Amylin Pharmaceuticals Inc • Pharmaceutical preparations • New York
At the option of the holder, holders may convert their notes, in multiples of $1,000 in principal amount, at any time on or after April 15, 2014 through the scheduled trading day immediately preceding the maturity date of June 15, 2014.